VINCRISTINE SULFATE PFS Drug Patent Profile
✉ Email this page to a colleague
When do Vincristine Sulfate Pfs patents expire, and what generic alternatives are available?
Vincristine Sulfate Pfs is a drug marketed by Hospira and Teva Pharms Usa and is included in two NDAs.
The generic ingredient in VINCRISTINE SULFATE PFS is vincristine sulfate. There are thirteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the vincristine sulfate profile page.
Summary for VINCRISTINE SULFATE PFS
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 48 |
Clinical Trials: | 477 |
Patent Applications: | 4,536 |
Formulation / Manufacturing: | see details |
DailyMed Link: | VINCRISTINE SULFATE PFS at DailyMed |
Recent Clinical Trials for VINCRISTINE SULFATE PFS
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Medical College of Wisconsin | Phase 1 |
Servier | Phase 1 |
AbbVie | Phase 1 |
Pharmacology for VINCRISTINE SULFATE PFS
Drug Class | Vinca Alkaloid |
Anatomical Therapeutic Chemical (ATC) Classes for VINCRISTINE SULFATE PFS
US Patents and Regulatory Information for VINCRISTINE SULFATE PFS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hospira | VINCRISTINE SULFATE PFS | vincristine sulfate | INJECTABLE;INJECTION | 071484-001 | Apr 19, 1988 | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Teva Pharms Usa | VINCRISTINE SULFATE PFS | vincristine sulfate | INJECTABLE;INJECTION | 075493-001 | Sep 1, 1999 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |